Live Breaking News & Updates on Pharmacist only

Stay informed with the latest breaking news from Pharmacist only on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Pharmacist only and stay connected to the pulse of your community

Bod Unveils Initial Schedule 3 CBD Candidate Trial Results

Australia's Bod Science has provided preliminary top-line results from its phase IIB clinical trial of a potential Schedule 3 CBD medicine.

Australia , Australian , Jo-patterson , Australia-therapeutic-goods-administration , Bod-science-limited , Therapeutic-goods-association , Therapeutic-goods-administration , Pharmacist-only , Bod-science ,

Did the paracetamol MR upschedule change overdose rates?

Did the paracetamol MR upschedule change overdose rates?
ajp.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ajp.com.au Daily Mail and Mail on Sunday newspapers.

Firouzeh-noghrehchi , Rose-cairns , Nicholas-buckley , Therapeutic-goods-administration , Pharmacist-only ,

Weed Week: Aussie companies jostle to become the world's supplier of medicinal cannabis

Weed Week: Aussie companies jostle to become the world’s supplier of medicinal cannabis

Australia , Canada , Denmark , Sydney , New-south-wales , Launceston , Tasmania , Mildura , Victoria , Australian , Danish , Rob-keldoulis

Emerging psychedelic therapies and investment opportunities

A new era of advanced medical therapies involving the controlled use of psychedelic drugs is underway. Breakthrough clinical research, accompanied by…

Germany , Auckland , New-zealand , Australia , United-states , United-kingdom , Canada , Otago , Australian , Mental-health , Austin-health

Bod Australia Low Dose CBD Product Progress

Will medical cannabis company Bod be the first to launch a low-dose CBD product available without prescription in Australia?

Australia , Jo-patterson , Therapeutic-goods-administration , Pharmacist-only , Bod-australia , Bod-bio-absorb ,

NZ Company Eyeing Australia's OTC CBD Market

New Zealand's Greenfern Industries Limited (GFI) has its sights set on registering an over-the-counter cannabidiol product in Australia.

Taranaki , New-zealand , Australia , Australian , Dan-casey , Australia-therapeutic-goods-administration , Greenfern-industries , Zealand-greenfern-industries-limited , Greenfern-industries-limited , Therapeutic-goods-administration , Pharmacist-only , Australian-register

"Over the counter low-dose cannabidiol: A viewpoint from the ACRE Capac" by Christine Mary Hallinan, Edward Eden et al.

"Over the counter low-dose cannabidiol: A viewpoint from the ACRE Capac" by Christine Mary Hallinan, Edward Eden et al.
uow.edu.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from uow.edu.au Daily Mail and Mail on Sunday newspapers.

Australia , Australian , Australian-centre-for-cannabinoid-clinical , Research-excellence , Prescription-only , Pharmacist-only , Australian-centre , Cannabinoid-clinical ,

Record Year For Australia's Medical Cannabis Approvals - WeedLife News Network

Record Year For Australia's Medical Cannabis Approvals
Wednesday, 13 January 2021
Australia’s Therapeutic Goods Administration approved 57,781 SAS (Special Access Scheme) Category B applications for unapproved medicinal cannabis products in 2020.
It was a huge year given the TGA has only approved 85,000 SAS Category B applications since this medicinal cannabis pathway was established way back in 1992. Here’s how 2020 shaped up for approvals for each month according to the TGA.
January – 3148
February – 3568
March – 3926
April – 3378
May – 4133
June – 4630
July – 5564
August – 5270
September – 6206
October – 5972
November – 6356
December – 5630
It should be noted approval numbers don’t reflect the number of patients receiving these medicines under the SAS as multiple approvals can be attributed to a single patient, and some patients may discontinue use of medicinal cannabis products.

Australia , Australians , Australian , Deb-lynch , Australia-therapeutic-goods-administration , Therapeutic-goods-administration , Special-access-scheme , Pharmacist-only , Australian-register , Therapeutic-goods , Politics , ஆஸ்திரேலியா